2,487
Views
22
CrossRef citations to date
0
Altmetric
Back Matter

Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation

, , , , , , , , , & show all
Article: 1737385 | Received 04 Feb 2019, Accepted 22 Jan 2020, Published online: 18 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Helena Nyström, Mats Jönsson, Mef Nilbert & Ana Carneiro. (2023) Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells. Acta Oncologica 62:1, pages 33-39.
Read now

Articles from other publishers (21)

Kang qiang Weng, Jin Yu Liu, Hu Li, Lin Lu She, Jun Liang Qiu, Hao Qi, Hui Yue Qi, Yong Sheng Li & Ying bo Dai. (2024) Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing. International Immunopharmacology 130, pages 111746.
Crossref
H.M. Abd Elmoneim, H.F. Huwait, H. Nafady-Hego & FEZ.A. Mohamed. (2023) PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING’S SARCOMA AND OSTEOSARCOMA. Experimental Oncology 45:3, pages 337-350.
Crossref
Jun Nishio & Shizuhide Nakayama. (2023) Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives. Diagnostics 13:19, pages 3022.
Crossref
Joshua D. Mannheimer, Gregory Tawa, David Gerhold, John Braisted, Carly M. Sayers, Troy A. McEachron, Paul Meltzer, Christina Mazcko, Jessica A. Beck & Amy K. LeBlanc. (2023) Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans. Communications Biology 6:1.
Crossref
Xiaolan Feng, Laurie Tonon, Haocheng Li, Elodie Darbo, Erin Pleasance, Nicolas Macagno, Armelle Dufresne, Mehdi Brahmi, Julien Bollard, Francoise Ducimetière, Marie Karanian, Alexandra Meurgey, Gaëlle Pérot, Thibaud Valentin, Frédéric Chibon & Jean-Yves Blay. (2023) Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers 15:14, pages 3705.
Crossref
My Linh D Vu, Andrew Berman, Erica Kao, Kristin Stoll & Lauren Lee. (2023) Safe and effective use of cabozantinib and nivolumab in stabilizing disease progression of tissue sarcoma after multiple lines of standard therapy. Journal of Case Reports and Images in Oncology 9:2, pages 1-6.
Crossref
Manuel Sánchez-de-la-Torre, Carolina Cubillos, Olivia J. Veatch, Francisco Garcia-Rio, David Gozal & Miguel Angel Martinez-Garcia. (2023) Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer. Cancers 15:4, pages 1061.
Crossref
Wei Wu, Haoyu Guo, Doudou Jing, Zhenhao Zhang, Zhicai Zhang, Feifei Pu, Wenbo Yang, Xin Jin, Xin Huang & Zengwu Shao. (2022) Targeted Delivery of PD‐L1‐Derived Phosphorylation‐Mimicking Peptides by Engineered Biomimetic Nanovesicles to Enhance Osteosarcoma Treatment. Advanced Healthcare Materials 11:23.
Crossref
Carolina Cubillos-Zapata, Elena Díaz-García & Francisco García-Río. 2022. Lung Diseases and Cancer. Lung Diseases and Cancer 1 14 .
Yang Wen, Fan Tang, Chongqi Tu, Francis Hornicek, Zhenfeng Duan & Li Min. (2022) Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential. Cancer Letters 547, pages 215887.
Crossref
Liyan Qu, Jiakang Jin, Jianan Lou, Chao Qian, Jinti Lin, Ankai Xu, Bing Liu, Man Zhang, Huimin Tao & Wei Yu. (2022) The nuclear transportation of PD-L1 and the function in tumor immunity and progression. Cancer Immunology, Immunotherapy 71:10, pages 2313-2323.
Crossref
Antonia Resag, Giulia Toffanin, Iva Benešová, Luise Müller, Vlatko Potkrajcic, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Antonio Rosato, Korinna Jöhrens, Franziska Eckert, Zuzana Strizova & Marc Schmitz. (2022) The Immune Contexture of Liposarcoma and Its Clinical Implications. Cancers 14:19, pages 4578.
Crossref
Kazuhiko Hashimoto, Shunji NishimuraYu ShinyashikiTomohiko ItoHiroki TanakaKazuhiro OhtaniRyosuke KakinokiMasao Akagi. (2022) PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report. Medicine 101:28, pages e29621.
Crossref
Alice Ko, Victoria S. Coward, Nalan Gokgoz, Brendan C. Dickson, Kim Tsoi, Jay S. Wunder & Irene L. Andrulis. (2022) Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma. Cancers 14:3, pages 548.
Crossref
Matthieu Roulleaux Dugage, Elise F. Nassif, Antoine Italiano & Rastislav Bahleda. (2021) Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Frontiers in Immunology 12.
Crossref
Andrew S. Brohl, Sivasish Sindiri, Jun S. Wei, David Milewski, Hsien-Chao Chou, Young K. Song, Xinyu Wen, Jeetendra Kumar, Hue V. Reardon, Uma S. Mudunuri, Jack R. Collins, Sushma Nagaraj, Vineela Gangalapudi, Manoj Tyagi, Yuelin J. Zhu, Katherine E. Masih, Marielle E. Yohe, Jack F. Shern, Yue Qi, Udayan Guha, Daniel Catchpoole, Rimas J. Orentas, Igor B. Kuznetsov, Nicolas J. Llosa, John A. Ligon, Brian K. Turpin, Daniel G. Leino, Shintaro Iwata, Irene L. Andrulis, Jay S. Wunder, Silvia R.C. Toledo, Paul S. Meltzer, Ching Lau, Beverly A. Teicher, Heather Magnan, Marc Ladanyi & Javed Khan. (2021) Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. Cell Reports 37:8, pages 110047.
Crossref
Zeger Rijs, Bernadette Jeremiasse, Naweed Shifai, Hans Gelderblom, Cornelis F. M. Sier, Alexander L. Vahrmeijer, Fijs W. B. van Leeuwen, Alida F. W. van der Steeg & Michiel A. J. van de Sande. (2021) Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review. Biomedicines 9:10, pages 1388.
Crossref
Siddh van Oost, Debora M. Meijer, Marieke L. Kuijjer, Judith V. M. G. Bovée & Noel F. C. C. de Miranda. (2021) Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?. Biomedicines 9:8, pages 1048.
Crossref
Luana Madalena Sousa, Jani Sofia Almeida, Tânia Fortes-Andrade, Manuel Santos-Rosa, Paulo Freitas-Tavares, José Manuel Casanova & Paulo Rodrigues-Santos. (2021) Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers 13:15, pages 3885.
Crossref
Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito & Masao Akagi. (2021) Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas. European Journal of Histochemistry 65:3.
Crossref
Mayanne M.T. Zhu, Elahe Shenasa & Torsten O. Nielsen. (2020) Sarcomas: Immune biomarker expression and checkpoint inhibitor trials. Cancer Treatment Reviews 91, pages 102115.
Crossref